Cite
HARVARD Citation
Sax, P. et al. (2018). Virological Outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in Antiretroviral-Naive HIV-1-Infected Participants with Baseline HIV-1 RNA ≥1, 000, 000 Copies/ml: A Post Hoc Analysis of Phase III Clinical Trials. Antiviral therapy. 23 (1), pp. 95-99. [Online].